Professor of Otolaryngology
Boston Children’s Hospital, Harvard Medical School
Boston, MA, United States
Dennis S. Poe, MD, PhD is a Professor of Otolaryngology at Harvard Medical School and a full-time faculty member of the Department of Otolaryngology and Communications Enhancement at Boston Children’s Hospital. He studied medicine at State University of New York Upstate Medical University, trained in otolaryngology at the University of Chicago, and did a neurotology fellowship in Nashville, Tennessee. He has spent his career in Boston, MA practicing otology/neurotology and skull base surgery. He has worked to develop minimally invasive endoscopic surgical techniques in this field and developed new procedures for Eustachian tube disorders. His research activities focus on otitis media and disorders of the Eustachian tube, specifically investigating the inflammatory basis of Eustachian tube dysfunction and conducting research on novel medical and surgical treatments. He completed a PhD in 2011 at the University of Tampere, Finland in Pathophysiology and Surgical Treatment of the Eustachian tube and did postdoctoral work with Prof. Ilmari Pyykkö, PI for the NanoEar European Union consortium on nanotechnology for targeted delivery of inner ear and middle ear therapy. He runs the International Eustachian Tube Study Group and was the principal investigator for a multicenter clinical trial of Balloon Dilation of the Eustachian Tube that paved the road for FDA approval for the balloon dilation device, which represented a significant achievement as it became the first ever treatment, medical or surgical, to be approved by the FDA. This milestone now opens the door for other medical and surgical treatments for ET disorders to follow.
Surgical Management of Obstructive Eustachian Tube Dysfunction
Sunday, September 29, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Eustachian Tube Dysfunction: Evidence and Controversies
Monday, September 30, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.